These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37741049)

  • 1. Targeted delivery of miR125a-5p and human Factor VIII attenuates molecular mediators of hemophilic arthropathy.
    Senthilkumar MB; Sarangi P; Amit S; Senguttuvan S; Kumar N; Jayandharan GR
    Thromb Res; 2023 Nov; 231():8-16. PubMed ID: 37741049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV mediated repression of Neat1 lncRNA combined with F8 gene augmentation mitigates pathological mediators of joint disease in haemophilia.
    Sarangi P; Senthilkumar MB; Amit S; Kumar N; Jayandharan GR
    J Cell Mol Med; 2024 Jun; 28(11):e18460. PubMed ID: 38864710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The F8(-/-) rat as a model of hemophilic arthropathy.
    Sørensen KR; Roepstorff K; Wiinberg B; Hansen AK; Tranholm M; Nielsen LN; Kjelgaard-Hansen M
    J Thromb Haemost; 2016 Jun; 14(6):1216-25. PubMed ID: 27060449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-15b Modulates Molecular Mediators of Blood Induced Arthropathy in Hemophilia Mice.
    Sen D; Jayandharan GR
    Int J Mol Sci; 2016 Apr; 17(4):492. PubMed ID: 27070581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
    Manon-Jensen T; Karsdal MA; Nielsen LN; Kjelgaard-Hansen M; Vandahl B; Olsen EH; Enoksson M; Roepstorff K
    J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor (NF)-κB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia.
    Sen D; Chapla A; Walter N; Daniel V; Srivastava A; Jayandharan GR
    J Thromb Haemost; 2013 Feb; 11(2):293-306. PubMed ID: 23231432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.
    Haxaire C; Hakobyan N; Pannellini T; Carballo C; McIlwain D; Mak TW; Rodeo S; Acharya S; Li D; Szymonifka J; Song X; Monette S; Srivastava A; Salmon JE; Blobel CP
    Blood; 2018 Sep; 132(10):1064-1074. PubMed ID: 29776906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Potential Feasibility of Intra-Articular Adeno-Associated Virus-Mediated Gene Therapy for Hemophilia Arthropathy.
    Zhang F; Yan X; Li M; Hua B; Xiao X; Monahan PE; Sun J
    Hum Gene Ther; 2020 Apr; 31(7-8):448-458. PubMed ID: 32079420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding.
    Wyseure T; Yang T; Zhou JY; Cooke EJ; Wanko B; Olmer M; Agashe R; Morodomi Y; Behrendt N; Lotz M; Morser J; von Drygalski A; Mosnier LO
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular remodeling underlies rebleeding in hemophilic arthropathy.
    Bhat V; Olmer M; Joshi S; Durden DL; Cramer TJ; Barnes RF; Ball ST; Hughes TH; Silva M; Luck JV; Moore RE; Mosnier LO; von Drygalski A
    Am J Hematol; 2015 Nov; 90(11):1027-35. PubMed ID: 26257191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia.
    Narkbunnam N; Sun J; Hu G; Lin FC; Bateman TA; Mihara M; Monahan PE
    J Thromb Haemost; 2013 May; 11(5):881-93. PubMed ID: 23413986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.
    Sun J; Hakobyan N; Valentino LA; Feldman BL; Samulski RJ; Monahan PE
    Blood; 2008 Dec; 112(12):4532-41. PubMed ID: 18716130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII.
    Chen H; Shi M; Gilam A; Zheng Q; Zhang Y; Afrikanova I; Li J; Gluzman Z; Jiang R; Kong LJ; Chen-Tsai RY
    Sci Rep; 2019 Nov; 9(1):16838. PubMed ID: 31727959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo.
    van Vulpen LFD; Popov-Celeketic J; van Meegeren MER; Coeleveld K; van Laar JM; Hack CE; Schutgens REG; Mastbergen SC; Lafeber FPJG
    J Thromb Haemost; 2017 Sep; 15(9):1788-1798. PubMed ID: 28696534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.
    Neumeyer J; Lin RZ; Wang K; Hong X; Hua T; Croteau SE; Neufeld EJ; Melero-Martin JM
    Blood Adv; 2019 Dec; 3(24):4166-4176. PubMed ID: 31851760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestation of hemophilia A in the absence of mutations in the F8 gene that encodes FVIII: role of microRNAs.
    Jankowska KI; McGill J; Pezeshkpoor B; Oldenburg J; Atreya CD; Sauna ZE
    Transfusion; 2020 Feb; 60(2):401-413. PubMed ID: 31785023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice.
    Cooke EJ; Wyseure T; Zhou JY; Gopal S; Nasamran CA; Fisch KM; Manon-Jensen T; Karsdal MA; Mosnier LO; von Drygalski A
    J Thromb Haemost; 2019 Nov; 17(11):1815-1826. PubMed ID: 31301687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
    Rangarajan S; Walsh L; Lester W; Perry D; Madan B; Laffan M; Yu H; Vettermann C; Pierce GF; Wong WY; Pasi KJ
    N Engl J Med; 2017 Dec; 377(26):2519-2530. PubMed ID: 29224506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
    Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
    J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.